Income Taxes (Details 2) - USD ($)	6 Months Ended	12 Months Ended
	Dec. 31, 2022	Jun. 30, 2022	Jun. 30, 2021
Income Taxes
Computed "expected" income tax benefit	$ (855,400)	$ 2,369,200	$ (1,014,300)
Research and development credits	(49,600)	(99,200)	(93,900)
Incentive Stock Option Expense	36,600	64,300	59,500
PPP Loan Foregivness	0	(91,100)	(111,700)
Valuation allowance	1,302,600	5,116,000	0
Aquila Biolabs GmbH operating loss	(245,700)	(717,100)	0
Differences between estimated financial income tax provision and actual filed tax return results	(187,800)	0	0
Other, net	(700)	491,100	7,900
Income tax expense /(benefit)	$ 0	$ (2,394,800)	$ (1,152,500)